Creating Value For Our Shareholders

Why Invest in Bayer

Report Highlights

q1 2021 button 190x107

Quarterly Statement First Quarter 2021

Investment Case

Event Highlights

May 27, 2021 at 8:30 a.m. CEST

Investor and Media Conference Call

Bayer announces five-point plan to effectively address potential future Roundup claims

Investor Conference Call

Q1 2021 Results

April 27, 2021

Virtual Event

Annual Stockholders' Meeting 2021

VIDEO-RECORDINGS

VIEW ALL EVENTS

News from Bayer

June 08, 2021

Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson’s disease

June 03, 2021

Not intended for U.S. and UK Media

Bayer acquires Noria and PSMA Therapeutics to expand portfolio in prostate cancer

May 27, 2021

Bayer announces five-point plan to effectively address potential future Roundup™ claims

Sustainability & Governance

Our Commitment to Sustainability

Discover More Investor Resources

Returning Value to Shareowners

Detailed Insight into Debt & Fixed Income

Discover Our Interactive Stock Charts

CORPORATE GOVERNANCE

Managing and Supervising an Enterprise

CONTACT IR TEAM

Get In Touch With Us

Subscribe To Our Latest Investor News

USES AND SAFETY RECORD

Let’s Talk About Glyphosate

Learn About The Litigation

Glyphosate Litigation Facts